Hospital CEOs Defend Pricing Amid Congressional Scrutiny

Hospital CEOs faced intense scrutiny at a House hearing on Tuesday, where they were accused of overcharging patients and exploiting the healthcare system. Executives from HCA Healthcare, CommonSpirit Health, New York-Presbyterian, and ECU Health testified before the House Ways and Means Committee, justifying their pricing strategies.

They argued that higher prices were warranted for services compared to independent practices. Hospitals accounted for nearly one-third of U.S. healthcare spending in 2024, amounting to about $1.6 trillion, according to a report in Health Affairs.

Additionally, a study published in JAMA Health Forum found that patients often pay more for doctor visits when the doctor is affiliated with a hospital or private equity firm. “The American people are fed up with outrageous prices that seem artificially high,” said Rep. Jason Smith, R-Mo., the committee’s chair.

Throughout the hearing, Republicans highlighted specific instances of high hospital charges at outpatient facilities. They pointed to facility fees that do not correspond with the quality of care provided but are used to cover costs such as staff and equipment.

Rep. David Kustoff, R-Tenn., cited an example from his state where an independent ambulatory surgical center charged a facility fee of $656 for a colonoscopy, while a hospital outpatient facility charged $1,222. “Is a 100% increase in the fee that you charge versus the surgical center, does that seem reasonable to you?” Kustoff asked the executives.

Rep. Greg Steube, R-Fla., echoed concerns, stating that patients at hospital-owned outpatient clinics face significantly higher charges compared to clinics run by physicians. “How can you justify facility fees on outpatient facilities when there is no meaningful difference in the care delivered or the quality of the care?” Steube questioned.

In response, the hospital CEOs defended their pricing, asserting that many hospitals are reimbursed below the cost of care, particularly by government programs like Medicare and Medicaid. They claimed that the higher prices reflect the superior quality of service provided at their facilities.

The contentious hearing highlights ongoing debates about healthcare costs and pricing transparency in the U.S. healthcare system.